地拉罗司分散片哪里买
Deferasirox (Enrige) is the first oral iron anthelmintic approved by the U.S. FDA for routine use, and is approved for use in patients ≥2 years old with chronic iron overload caused by blood transfusion. The daily dosage of Deferasirox (Enrig) dispersible tablets is 20~30 mg/kg, once a day, and the clinical compliance is good. In addition to chelating intracellular iron, Deferasirox (Enrig) is also related to the increase of hepcidin, which can reduce the iron absorption of intestinal cells, so the iron removal effect is better. Patients should undergo detailed examination before receiving deferasirox (Enrige) treatment and strictly follow the doctor's diagnosis and treatment recommendations.
Where to buy deferasirox dispersible tablets? It is understood that the original version of Deferasirox (Enriga) launched by Novartis in India is 400mg*30 tablets/box, priced at about RMB 700, while CIPLA Pharmaceuticals, one of the famous Indian pharmaceutical companies, has launched a generic version of Deferasirox (Enrig), with a specification of 500mg*30 tablets/box, priced at about RMB 500. The price is much lower than the original drug. For patients who need to take this drug for long-term treatment, the price of the Indian generic version of Deferasirox (Enrige) is more acceptable.
Although it is a generic drug, its efficacy is almost the same as that of the original drug, it has the same effect, and the price is more affordable and cost-effective, which is why it has become the choice of many patients. Patients can choose to go abroad to purchase Deferasirox (Enrige) by themselves, but it is not recommended to purchase the drug through purchasing agents. Since the exchange rate floating price is not fixed, if patients want to know the specific price of the drug, or want to purchase Deferasirox (Enrego) overseas, they can consult with domestic reliable overseas medical service institutions (such as Medical Companion Travel).
The above is an introduction to the purchasing channels of Deferasirox (Enrego). I hope it can help everyone. If patients have other questions about the drug, they can consult the medical companion service.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)